Holmusk Overview

  • Year Founded
  • 2015

Year Founded

  • Status
  • Private

  • Employees
  • 101

Employees

  • Latest Deal Type
  • Later Stage VC

  • Investors
  • 14

Holmusk General Information

Description

Developer of a real-world evidence platform designed to advance behavioral health analytics and improve clinical understanding. The company's platform incorporates a longitudinal de-identified database and more than one million patients, combines natural language processing, predictive disease models, and analytics dashboards, enabling researchers, healthcare providers, and payers to derive evidence-based insights for treatment development, care delivery optimization, and regulatory decision-making.

Contact Information

Website
www.holmusk.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 2nd Floor
  • 54 Thompson Street
  • New York, NY 10012
  • United States
+1 (917)
Primary Industry
Enterprise Systems (Healthcare)
Corporate Office
  • 2nd Floor
  • 54 Thompson Street
  • New York, NY 10012
  • United States
+1 (917)

Holmusk Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Holmusk Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
10. Later Stage VC 26-Nov-2025 Completed Generating Revenue
9. Later Stage VC 12-Oct-2023 Completed Generating Revenue
8. Later Stage VC (Series B) 06-Jan-2023 Completed Generating Revenue
7. Later Stage VC (Series A1) 07-Apr-2020 Completed Generating Revenue
6. Accelerator/Incubator 01-Jul-2019 Completed Generating Revenue
5. Accelerator/Incubator Completed Generating Revenue
4. Accelerator/Incubator 01-Feb-2019 Completed Generating Revenue
3. Early Stage VC (Series A) 25-Sep-2018 Completed Generating Revenue
2. Seed Round 02-Nov-2016 $2.32M $2.32M Completed Startup
1. Angel (individual) Completed Startup
To view Holmusk’s complete valuation and funding history, request access »

Holmusk Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series B
Series A1
Series A 319,364 $17.45 $17.45 1x $17.45 6.87%
Seed 149,500 $15.51 $15.51 1x $15.51 3.22%
To view Holmusk’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Holmusk Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a real-world evidence platform designed to advance behavioral health analytics and improve clinical underst
Enterprise Systems (Healthcare)
New York, NY
101 As of 2025

New York, NY
 

San Francisco, CA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Holmusk Competitors (43)

One of Holmusk’s 43 competitors is Komodo Health, a Venture Capital-Backed company based in New York, NY.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Komodo Health Venture Capital-Backed New York, NY
Innovaccer Venture Capital-Backed San Francisco, CA
Lumeon Formerly VC-backed South Jordan, UT
HealthVerity Venture Capital-Backed Philadelphia, PA
Relatient Private Equity-Backed Atlanta, GA
You’re viewing 5 of 43 competitors. Get the full list »

Holmusk Patents

Holmusk Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2022231518-A1 Systems and methods for retaining and analyzing health information Inactive 28-Apr-2021

Holmusk Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Holmusk Investors (14)

Investor Name Investor Type Holding Investor Since Participating Rounds
Capikris Foundation Venture Capital Minority
dRx Capital Novartis Venture Capital Minority
Johnson & Johnson JJDC Corporate Venture Capital Minority
Northwell Holdings Corporate Venture Capital Minority
Novartis Corporation Minority
You’re viewing 5 of 14 investors. Get the full list »

Holmusk Acquisitions (2)

Holmusk’s most recent deal was a Merger/Acquisition with Otsuka Health Solutions. The deal was made on 27-Apr-2021.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Otsuka Health Solutions 27-Apr-2021 Merger/Acquisition Business/Productivity Software
MindLinc 22-Mar-2016 Merger/Acquisition Medical Records Systems
To view Holmusk’s complete acquisitions history, request access »

Holmusk FAQs

  • When was Holmusk founded?

    Holmusk was founded in 2015.

  • Where is Holmusk headquartered?

    Holmusk is headquartered in New York, NY.

  • What is the size of Holmusk?

    Holmusk has 101 total employees.

  • What industry is Holmusk in?

    Holmusk’s primary industry is Enterprise Systems (Healthcare).

  • Is Holmusk a private or public company?

    Holmusk is a Private company.

  • What is Holmusk’s current revenue?

    The current revenue for Holmusk is .

  • How much funding has Holmusk raised over time?

    Holmusk has raised $114M.

  • Who are Holmusk’s investors?

    Capikris Foundation, dRx Capital Novartis, Johnson & Johnson JJDC, Northwell Holdings, and Novartis are 5 of 14 investors who have invested in Holmusk.

  • Who are Holmusk’s competitors?

    Komodo Health, Innovaccer, Lumeon, HealthVerity, and Relatient are some of the 43 competitors of Holmusk.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process